Journal article
2021-07-01T00:00:00+00:00
117
e110 - e113
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Humans, Cardiovascular Diseases, Anti-Inflammatory Agents, Fibrinolytic Agents, Antiviral Agents, Treatment Outcome, Cause of Death, Risk Assessment, Research Design, Time Factors, Aged, Middle Aged, Female, Male, COVID-19, Heart Disease Risk Factors, COVID-19 Drug Treatment